Pharma-Bio Serv Statistics
Total Valuation
Pharma-Bio Serv has a market cap or net worth of 13.30 million. The enterprise value is 3.00 million.
| Market Cap | 13.30M |
| Enterprise Value | 3.00M |
Important Dates
The last earnings date was Friday, June 13, 2025.
| Earnings Date | Jun 13, 2025 |
| Ex-Dividend Date | Feb 28, 2025 |
Share Statistics
Pharma-Bio Serv has 22.93 million shares outstanding. The number of shares has decreased by -0.08% in one year.
| Current Share Class | 22.93M |
| Shares Outstanding | 22.93M |
| Shares Change (YoY) | -0.08% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 54.93% |
| Owned by Institutions (%) | 1.49% |
| Float | 8.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.27 |
| PS Ratio | 1.38 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.88 |
| EV / Sales | 0.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.02 |
Financial Position
The company has a current ratio of 7.54, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.54 |
| Quick Ratio | 7.35 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.08 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.45% and return on invested capital (ROIC) is -3.43%.
| Return on Equity (ROE) | -1.45% |
| Return on Assets (ROA) | -2.95% |
| Return on Invested Capital (ROIC) | -3.43% |
| Return on Capital Employed (ROCE) | -5.99% |
| Revenue Per Employee | 128,531 |
| Profits Per Employee | -2,523 |
| Employee Count | 75 |
| Asset Turnover | 0.63 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5,330 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.49% in the last 52 weeks. The beta is 0.71, so Pharma-Bio Serv's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -10.49% |
| 50-Day Moving Average | 0.50 |
| 200-Day Moving Average | 0.53 |
| Relative Strength Index (RSI) | 57.03 |
| Average Volume (20 Days) | 6,991 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, Pharma-Bio Serv had revenue of 9.64 million and -189,194 in losses. Loss per share was -0.01.
| Revenue | 9.64M |
| Gross Profit | 2.95M |
| Operating Income | -726,425 |
| Pretax Income | -194,524 |
| Net Income | -189,194 |
| EBITDA | -687,603 |
| EBIT | -726,425 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 10.41 million in cash and 113,044 in debt, giving a net cash position of 10.29 million or 0.45 per share.
| Cash & Cash Equivalents | 10.41M |
| Total Debt | 113,044 |
| Net Cash | 10.29M |
| Net Cash Per Share | 0.45 |
| Equity (Book Value) | 12.12M |
| Book Value Per Share | 0.53 |
| Working Capital | 11.64M |
Cash Flow
In the last 12 months, operating cash flow was -1.32 million and capital expenditures -163,181, giving a free cash flow of -1.49 million.
| Operating Cash Flow | -1.32M |
| Capital Expenditures | -163,181 |
| Free Cash Flow | -1.49M |
| FCF Per Share | -0.06 |
Margins
Gross margin is 30.59%, with operating and profit margins of -7.54% and -1.96%.
| Gross Margin | 30.59% |
| Operating Margin | -7.54% |
| Pretax Margin | -2.02% |
| Profit Margin | -1.96% |
| EBITDA Margin | -7.13% |
| EBIT Margin | -7.54% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 12.93%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 12.93% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.08% |
| Shareholder Yield | 12.58% |
| Earnings Yield | -1.42% |
| FCF Yield | -11.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharma-Bio Serv has an Altman Z-Score of 7.05 and a Piotroski F-Score of 2.
| Altman Z-Score | 7.05 |
| Piotroski F-Score | 2 |